159 related articles for article (PubMed ID: 26908438)
1. Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC).
Prizment AE; Linabery AM; Lutsey PL; Selvin E; Nelson HH; Folsom AR; Church TR; Drake CG; Platz EA; Joshu C
Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):657-64. PubMed ID: 26908438
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of serum beta-2-microglobulin as a predictor of diabetic complications in patients with type 2 diabetes without renal impairment.
Kim MK; Yun KJ; Chun HJ; Jang EH; Han KD; Park YM; Baek KH; Song KH; Cha BY; Park CS; Kwon HS
Diabetes Metab; 2014 Dec; 40(6):459-65. PubMed ID: 25303803
[TBL] [Abstract][Full Text] [Related]
3. Change in novel filtration markers and risk of ESRD.
Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
[TBL] [Abstract][Full Text] [Related]
4. Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study.
Prizment AE; Folsom AR; Dreyfus J; Anderson KE; Visvanathan K; Joshu CE; Platz EA; Pankow JS
Cancer Causes Control; 2013 Dec; 24(12):2077-87. PubMed ID: 24036889
[TBL] [Abstract][Full Text] [Related]
5. Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis.
Amighi J; Hoke M; Mlekusch W; Schlager O; Exner M; Haumer M; Pernicka E; Koppensteiner R; Minar E; Rumpold H; Schillinger M; Wagner O
Stroke; 2011 Jul; 42(7):1826-33. PubMed ID: 21546482
[TBL] [Abstract][Full Text] [Related]
6. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies.
Wilson AM; Kimura E; Harada RK; Nair N; Narasimhan B; Meng XY; Zhang F; Beck KR; Olin JW; Fung ET; Cooke JP
Circulation; 2007 Sep; 116(12):1396-403. PubMed ID: 17724262
[TBL] [Abstract][Full Text] [Related]
7. Lower serum beta-2 microglobulin levels are associated with worse survival in incident peritoneal dialysis patients.
Chang TI; Lim H; Park CH; Park KS; Park JT; Kang EW; Yoo TH; Kang SW; Han SH
Nephrol Dial Transplant; 2019 Jan; 34(1):138-145. PubMed ID: 29955831
[TBL] [Abstract][Full Text] [Related]
8. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
Liabeuf S; Lenglet A; Desjardins L; Neirynck N; Glorieux G; Lemke HD; Vanholder R; Diouf M; Choukroun G; Massy ZA;
Kidney Int; 2012 Dec; 82(12):1297-303. PubMed ID: 22895515
[TBL] [Abstract][Full Text] [Related]
9. Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma.
Yoo C; Yoon DH; Kim S; Huh J; Park CS; Park CJ; Lee SW; Suh C
Hematol Oncol; 2016 Mar; 34(1):22-7. PubMed ID: 25689467
[TBL] [Abstract][Full Text] [Related]
10. Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.
Gross M; Top I; Laux I; Katz J; Curran J; Tindell C; Agus D
Clin Cancer Res; 2007 Apr; 13(7):1979-86. PubMed ID: 17404077
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
[TBL] [Abstract][Full Text] [Related]
13. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.
Limburg PJ; Stolzenberg-Solomon RZ; Vierkant RA; Roberts K; Sellers TA; Taylor PR; Virtamo J; Cerhan JR; Albanes D
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1514-21. PubMed ID: 17162243
[TBL] [Abstract][Full Text] [Related]
14. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
15. Fasting serum glucose level and cancer risk in Korean men and women.
Jee SH; Ohrr H; Sull JW; Yun JE; Ji M; Samet JM
JAMA; 2005 Jan; 293(2):194-202. PubMed ID: 15644546
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study identified the human leukocyte antigen region as a novel locus for plasma beta-2 microglobulin.
Tin A; Astor BC; Boerwinkle E; Hoogeveen RC; Coresh J; Kao WH
Hum Genet; 2013 Jun; 132(6):619-27. PubMed ID: 23417110
[TBL] [Abstract][Full Text] [Related]
17. Renal function and long-term mortality in patients with asymptomatic carotid atherosclerosis.
Hoke M; Pernicka E; Niessner A; Goliasch G; Amighi J; Koppensteiner R; Minar E; Mlekusch W; Rumpold H; Wagner O; Schillinger M
Thromb Haemost; 2012 Jan; 107(1):150-7. PubMed ID: 22116452
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status.
Koelzer VH; Baker K; Kassahn D; Baumhoer D; Zlobec I
J Clin Pathol; 2012 Nov; 65(11):996-1002. PubMed ID: 22859396
[TBL] [Abstract][Full Text] [Related]
19. Repeated measurements of serum carotenoid, retinol and tocopherol levels in relation to colorectal cancer risk in the Women's Health Initiative.
Kabat GC; Kim MY; Sarto GE; Shikany JM; Rohan TE
Eur J Clin Nutr; 2012 May; 66(5):549-54. PubMed ID: 22166899
[TBL] [Abstract][Full Text] [Related]
20. Association of beta-2-microglobulin with cardiovascular and all-cause mortality in the general and non-CKD population.
Fang H; Zhang Q; Jin L
Medicine (Baltimore); 2023 Mar; 102(11):e33202. PubMed ID: 36930114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
